Scinai Immunotherapeutics Ltd

SCNI

Company Profile

  • Business description

    Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

  • Contact

    Hadassah Ein Kerem Campus
    2nd Floor, Jerusalem BioPark
    Jerusalem
    ISR

    T: +972 89302529

    https://www.scinai.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    31

Stocks News & Analysis

stocks

Apple earnings: Strong performance overpowers headwinds, and we raise our FVE

Our view of Apple shares.
stocks

Coles is winning the supermarket wars but is Woollies the better long-term opportunity?

Our view after first quarter sales updates.
stocks

Microsoft earnings: Strong, including Azure, but overall guidance is in line

We think Microsoft stock is moderately undervalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,182.5024.000.26%
CAC 408,109.7911.28-0.14%
DAX 4024,132.41174.110.73%
Dow JONES (US)47,368.75194.12-0.41%
FTSE 1009,701.3715.88-0.16%
HKSE26,158.36251.710.97%
NASDAQ23,896.85171.890.72%
Nikkei 22552,411.341,085.732.12%
NZX 50 Index13,556.307.980.06%
S&P 5006,860.0519.850.29%
S&P/ASX 2008,894.8036.200.41%
SSE Composite Index3,976.5221.730.55%

Market Movers